News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Skye Bioscience marks SBI-100 clinical trial progress with new clinical research organization

Skye Bioscience Inc

Skye Bioscience CEO Punit Dhillon joined Proactive's Natalie Stoberman to share the latest progress on its SBI-100 Ophthalmic Emulsion (OE) clinical trials. SBI-100 OE, the company's lead program, is focused on developing a treatment for glaucoma, the world's leading cause of irreversible blindness. Skye Bioscience is a pharmaceutical company unlocking the potential of cannabinoids through the development of its proprietary cannabinoid derivatives to treat diseases with significant unmet needs. Contact Details Proactive Investors US +1 347-449-0879 na-editorial@proactiveinvestors.com

February 08, 2023 07:19 AM Eastern Standard Time

Video
Article thumbnail News Release

UC Asset Signed 2nd MoU to Speed Up Phase I of $4M Cannabis Deal

UC Asset LP

McapMediawire -- UC Asset LP (OTCQB: UCASU ) announced today that the company has signed second MOU on its recently announced deal of $4 million cannabis property transaction in the State of Oklahoma. Four weeks ago, UCASU entered into a MOU to acquire a 10,000 square foot cannabis cultivation property using $3 million non-cash payment, and to invest $1 million cash to build extra 5,000 square feet of facility at the same site. The new MOU details on what UCASU calls “Phase I” of the deal. In this Phase I, UC Asset will acquire 20% of ownership in the said property using non-cash payment of 500,000 preferred shares, and then will invest $1 million cash for the aforementioned expansion of the cultivation facility, while increasing UC Asset’s ownership to 50%. UC Asset will have the option to acquire the remained 50% ownership of the property by issuing 2 million preferred shares. “The updated plan of Phase I enables us to expediate the construction of the extra 5,000 square feet of cannabis cultivation facility, and therefore it will speed up the return from our investment,” claims Larry Wu, founder of UC Asset. “Now we are expecting to receive monthly payment after 3 months, in comparison to the previous plan under which we will only be paid after 6 months.” This expedition is a win-win solution for both parties, according to Wu. The State of Oklahoma will hold a special election in March to decide on marijuana legalization. It is projected that the result will be in favor of legalization. For this reason, it is very desirable to complete the said expansion of growing facility as soon as possible, possibly right after the legalization of recreational marijuana within the state. Most other terms and conditions remain the same, including the amount of monthly payment that UC Asset will receive, which will represent a 14.4% cash on cash annual return. It will still include protective terms for existing shareholders, so that the issuance of 500,000 preferred shares will not dilute the value of holdings by existing shareholders, particularly, it will not dilute dividends allocated to existing shareholders. This is possible since the preferred shares are not entitled to receive dividends unless converted into common shares, and the holder of preferred shares can only convert when revenue from the property has increased to a certain level. This 10,000 square foot cannabis property, according to UC Asset, is built to the state-of-art standard, with computerized and automatized environment control, and has the capacity to host full cycle cannabis production from creating clones/genetics to extracting cannabinoids. UC Asset has set a goal of $1 million gross profit for the year of 2023. And the speed-up of this deal will likely help UC Asset to reach that goal. About UC Asset LP UC Asset LP is a limited partnership formed for the purpose of investing in real estate with innovative strategies. For more information about UC Asset, please visit: www.ucasset.com Disclaimer: This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed. For More Information Contact: IR@UCasset.com Contact Details Larry Wu IR@UCasset.com Company Website http://www.ucasset.com/

February 07, 2023 12:43 PM Eastern Standard Time

Article thumbnail News Release

Context Therapeutics announces positive responses in Phase 2 OATH clinical trial

Context Therapeutics

Context Therapeutics CEO Marty Lehr joined Proactive's Natalie Stoberman to announce two clinical responses from its Phase 2 OATH Clinical Trial. Lehr said two patients have achieved a confirmed partial response among the first 12 patients enrolled in the trial evaluating the potential of ONA-XR in combination with anastrozole to treat hormone receptor-positive metastatic endometrial cancer. The findings are encouraging as ONA-XR exhibits initial signals of clinical activity and confirmed tumor shrinkage, Lehr added. Contact Details Proactive Investors USA +1 347-449-0879 na-editorial@proactiveinvestors.com

February 07, 2023 12:21 PM Eastern Standard Time

Video
Article thumbnail News Release

Avicanna completes first international export of cannabis seeds between Colombia and Spain

Avicanna Inc

Avicanna CEO Aras Azadian joined Proactive's Natalie Stoberman to discuss the completion of its first export of feminized cannabis seeds to Spain. Azadian said the company's majority-owned Colombian subsidiary, Santa Marta Golden Hemp SAS, sent its first commercial export of feminized cannabis seeds to Spain. The seeds are part of the Aureus portfolio of products which also includes proprietary genetics in the form of feminized seeds, cannabinoid extracts and purified compounds including CBD, CBG and THC. Contact Details Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

February 07, 2023 12:14 PM Eastern Standard Time

Video
Article thumbnail News Release

Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals

Braxia Scientific Corp.

Braxia Scientific CEO Dr Roger McIntyre joined Steve Darling from Proactive to share news the company has agreed to a non-binding amended and restated letter of intent for a business combination with Irwin Naturals Inc. McIntyre told Proactive the transaction assembles an experienced management and scientific team in mental health treatment, research and development. The combined company will have 17 specialized mental health clinics across North America, an enhanced telehealth platform and access to critical treatments for millions of people across multiple states in the US. Contact Details Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

February 07, 2023 12:02 PM Eastern Standard Time

Video
Article thumbnail News Release

Intus Care Announces Oracle Health Chairman Dr. David Feinberg Has Joined Its Board of Directors

Intus Care

Intus Care, developer of an innovative predictive analytics platform designed for geriatric health, today announced that David Feinberg, MD, Chairman of Oracle Health, has joined its esteemed board of directors. David is committed to making healthcare more accessible, affordable, and equitable. His goals are well-aligned with Intus Care’s mission of enabling more effective geriatric care by empowering care providers through data to make more informed decisions. David’s work at Oracle has served to advance access to critically needed data through an open and connected healthcare ecosystem. Previously, David served as president and CEO of Cerner, the healthcare IT industry leader which was acquired by Oracle in June of 2022. David led Cerner teams focused on delivering tools and technology to improve the patient and caregiver experience. “As CEO of Cerner, and now in his role at Oracle, few people understand the healthcare IT landscape and the importance of empowering care providers with better technologies like David does,” said Robbie Felton, CEO, Intus Care. “He recognizes the value of leveraging patient data in more meaningful ways, a mission which Intus Care shares.” Intus Care is continuing to expand its PACE partnerships and aiming to scale its work with special needs plans and other senior care entities across the healthcare spectrum to provide high quality care to vulnerable older adult populations. “I’m excited to join the Intus Care Board of Directors. The work they’re doing is going to allow data that care providers are already collecting to go much further in terms of improving care outcomes,” said David. “Intus Care is already proving through its work with PACE programs across the country that they have what it takes to allow routine data to be used to make hard-to-see correlations that can reduce patient complications and improve overall patient care.” Prior to his position at Cerner, David served as president and CEO of both UCLA Health and Geisinger Health prior to assuming leadership of Google Health in early 2019. He earned his MD from Chicago Medical School in 1989, finishing at the top of his class and is a member of the Alpha Omega Alpha Medical Honor Society. He also holds an economics degree from the University of California-Berkeley and an MBA from Pepperdine University. About Intus Care Intus Care synthesizes data to improve care and reduce hospitalizations for some of the most socially vulnerable and clinically complex patients in today’s healthcare system – senior citizens. Through a unique predictive analytics platform and data-driven consulting services, Intus Care empowers managed care organizations such as PACE programs, special needs plans, long-term care facilities, and more. It integrates with existing electronic health records, claims, and financial software to automatically extract and analyze data. By highlighting participant risk and data-driven improvement strategies, Intus Care empowers providers and organizations to improve outcomes. Visit our website to learn more and to sign up for our newsletter intuscare.com. PR Contact Jordan Bouclin and Erika Harris SVM Public Relations and Marketing Communications intuscare@svmpr.com (401)490-9700 Contact Details SVM Public Relations +1 401-490-9700 intuscare@svmpr.com Company Website https://www.intuscare.com/

February 07, 2023 10:00 AM Eastern Standard Time

Article thumbnail News Release

Uninsured And Underinsured Americans Are Saving 10% To 60% On Dental Care Thanks To DentalPlans.com

DentalPlans.com

By Rachael Green, Benzinga Open enrollment for employer-sponsored health insurance ended last week in most states, but an estimated 29% of adults still don’t have dental coverage. That’s due, in part, to the fact that dental care is often treated as something separate from healthcare. The Affordable Care Act doesn’t even include dental coverage as part of its ten essential health benefits that all plans must include, despite the fact that poor oral health has been linked to heart disease and other serious chronic health problems. The good news for those millions of Americans who missed out on dental insurance: dental savings plans are open to join year-round and can reduce the cost of dental care by 10% to 60% depending on the procedure and plan. DentalPlans.com, a leading marketplace of dental savings plans operating since 1999, makes it easy to find the right savings plan to make quality oral health affordable regardless of insurance status. Oral Health Is More Important Than You Might Think While it’s not classified as essential, the data proves that oral health is extremely important to our overall health. Bacteria and inflammation that start in the mouth can also spread to other areas and contribute to other health problems like heart disease, poor pregnancy outcomes and pneumonia. Chronic health conditions like diabetes and osteoporosis have also been linked to increased risk for gum disease and tooth decay. Physical health aside, missing teeth and other signs of poor oral health can hurt a person’s financial and social well-being, too. According to the American Dental Association, 30% of low-income adults face limitations in job interviews due to the condition of their mouth and teeth. Dental Savings Plans Help Make Improved Oral Health More Accessible Despite the growing body of research that shows how important oral health is to a person’s overall health and quality of life, dental care is still not covered by original Medicare and most state Medicaid programs include either no coverage at all, limited coverage for emergency care only, or coverage that’s capped at low annual maximums. In states that do provide coverage, those annual maximums range from just $500 in Arkansas up to $1,150 in Alaska. Even most private dental plans come with annual maximums that cap out at under $2,000 on average. Those annual limits are rarely enough to cover the full cost of even one big ticket procedure, like dental implants or root canals. As a result, adults who need anything beyond routine cleanings and exams either have to foot the bill for dental work themselves or look for supplemental plans to cover this gap in coverage. That’s where DentalPlans.com comes in. The dental savings plans marketplace provides a searchable database where visitors can find a dental savings plan that offers savings at their preferred dentist or discounts for the specific procedure they need. In exchange for a low annual membership fee, plan members of a dental savings plan enjoy discounts of between 10% to 60% off of the full price of dental procedures ranging from routine cleanings and exams to more specialized restorative and orthodontic procedures. More than 140,000 dentists, representing over 70% of practicing dentists in the United States, participate in dental savings plans. Once they join, a plan member simply has to show their membership card at the participating dentist’s office to get the discounted rate. Plans activate quickly and there are no annual limits or restrictions based on current health conditions. In one example provided on the site, a family of two adults and two children pays an annual family membership fee of $209.95 for the Careington Care 500 Series savings plan. Without the plan, a routine six-month checkup would cost $73 per person, a teeth cleaning visit would cost $122 per adult and $84 per child, and x-rays would cost $80 per person. That means the standard preventative care recommended would cost $1,316 for the family without insurance. With the example savings plan, a routine six-month checkup costs $19 per person, a teeth cleaning visit costs $39 per adult and $31 per child, and x-rays cost $21 per person. Those discounts bring the total cost for the family down to $396, representing over 55% savings even when you add the annual membership fee back in. Sample savings are based on zip code 43614, actual costs and savings may vary by service and geographical area. If anyone in that family also needed restorative care like fillings, crowns, or root canals, their dental savings plan would allow them to save hundreds or thousands on those more expensive and very important procedures. For those without dental insurance, a dental savings plan can make essential preventative care affordable and substantially lower the cost of restorative and emergency dental care. For those with dental insurance, the discounts that come with membership can help lower the out-of-pocket costs they are responsible for after they surpass their insurance plan’s annual maximum. While the two can’t be used on the same procedure, dentists can help patients who need multiple procedures (such as a root canal followed by a crown and filling) coordinate a care plan that maximizes their insurance coverage and their dental savings plan discounts. To learn more visit DentalPlans.com This article was originally published on Benzinga here. DentalPlans.com, founded in 1999, is a leading online marketplace for dental savings plans in the U.S., helping more than a million people to affordably access quality healthcare services. Our mission is to empower consumers with the tools, information, and services that they need to live happier, healthier lives. This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Contact Details Matthew Wong matthew.wong@wpromote.com Company Website https://www.dentalplans.com/

February 07, 2023 09:15 AM Eastern Standard Time

Article thumbnail News Release

Dr. Muneeb Shah– TikTok’s Famous “DermDoctor”- Joins CORTINA to Broaden Access to Dermatology Care

Cortina Health

Dr. Muneeb Shah– known widely in social media as “ DermDoctor ” or “ Doctorly ” is the #1 dermatology influencer worldwide. With an ever-increasing number of followers reaching over 20 million across his platforms, Dr. Shah has become a trusted advisor for anyone seeking skincare education and dermatology, by creating content that is as informative as it is entertaining. He is a board-certified dermatologist with a passion for skincare education and improving healthcare access. “DermDoctor” recognizes social media as a powerful tool in bringing healthcare education to millions of people who lack the resources to get it otherwise. Dr. Shah points out that, “There is a real access issue in the United States with healthcare. In certain areas, you cannot see a dermatologist…so there is a massive gap between patients and medical care that needs to be filled. ” It is precisely this gap he seeks to fill, debunking skin-related myths and guiding his online community in their skin and dermatology needs. Furthermore, he emphasizes the importance of board-certified dermatologists in diagnosing and treating skin conditions and the impactful role teledermatology can play in providing access to proper medical care: “When access to an in-person visit is not feasible, many skin conditions can be diagnosed and treated virtually by a dermatologist with proper data. Pairing Cortina’s next-generation technology with its network of board-certified dermatologists is the innovative solution dermatology patients need. That’s why I am proud to be advising Cortina’s team to improve access.” In addition to bringing attention to a seamless solution for diagnosing and treating skin conditions, Dr. Shah is passionate about minimizing misdiagnosis. A common condition that gets overlooked is rosacea as it typically resembles acne or a sunburn. Dr. Shah and Cortina’s first of many educational assets under the medical content advisor role is an informational YouTube video that can be found on Doctorly, discussing key indicators and treatments for both skin conditions in depth. Cortina Health is the only all-inclusive teledermatology platform providing patients with access to board-certified dermatologists who diagnose and prescribe personalized compounded medications which are shipped directly to the patient’s door. Cortina offers convenient, affordable and effective dermatology care to treat the most common skin conditions in all 50 states, no insurance required. Founded by Harvard Medical School Adjunct Professor, Dr. Reid Maclellan, Cortina’s ethos aligns perfectly with Dr. Shah’s vision. “I am thrilled to welcome Dr. Muneeb Shah as our Medical Content Advisor. This is a significant step in our goal to democratize dermatology care. His expertise and reach combined with Cortina’s capabilities and network of board-certified dermatologists, strengthen our commitment to patients seeking dermatology care anytime, anywhere. We are delighted to count Dr. Shah among our leadership as we merge technology, medicine, and high-quality care for all”, states Dr. Maclellan. ABOUT CORTINA At Cortina, we are passionate about personalized medicine and believe everyone deserves access to high-quality, effective treatments to feel good in their own skin. When it comes to skincare, we know there is no one-size-fits-all approach. Cortina makes elite dermatology care for the most common skin conditions convenient and accessible in all 50 states. Merging modern medicine and modern convenience, our team is committed to changing healthcare for the better. Cortina seeks to build confidence and improve the quality of life of its patients by bringing U.S. board-certified dermatologists and clinically proven, FDA-approved treatments right to their door at an affordable price. Contact Details Cortina Health Juliana Martins juliana@eleven11mediarelations.com Company Website https://www.getcortina.com/

February 07, 2023 09:07 AM Eastern Standard Time

Video Image
Article thumbnail News Release

Freedom Holdings Closes with MEDcann Industries, Inc.

FREEDOM HLDG INC.

MCapMediaWire -- Freedom Holdings, Inc. aka Freedom Acquisition Corp (OTC: FHLD ) (“FHLD” or the "Company”), is pleased to announce that it has closed on the Definitive Agreement with MEDcann Industries as announced. The Closing took place on February 3, 2023, and the terms of the agreement have been consummated as follows: MedCann has purchased 40,000,000 Freedom restricted common shares for $50,000.00 and Brian Kistler has resigned all Officer/Director positions only to serve as an advisor for a period of 2 years to insure a smooth transition and John Vivian, CEO of MedCann has been appointed as the Chairman and CEO of Freedom, Robin Wright as C.F.O. and MEDcann (as the parent company) has assumed the debt and ongoing operational costs of Freedom. All financial disclosures are to be brought current. Brian Kistler, outgoing CEO, and Director stated: “This opportunity for the Company to take on the operations of MedCann Industries as a majority owned subsidiary will launch Freedom into the lucrative Cannabis industry for future development. I am pleased for the control of the Company to be taken over by the new management for a breath of new life for all of the shareholders.” John Vivian, incoming CEO and Chairman of the Board commented “I want to thank Brian for his confidence in our ability to take Freedom to new levels of shareholder value as we execute our plan of moving all operations into Freedom just as soon it is possible. We will update our shareholders as the plan unfolds.” “I am also pleased to have Ms. Wright join me on the Board of Directors and believe that our future is bright with their influence and expertise” concluded Vivian. BUSINESS DESCRIPTION: MEDcann Industries, Inc. - Medical Cannabis, Inc. is a developer and provider of next generation Cannabis driven products such as CBD & THC, cannabis 420 beverages, and Medical treatment solutions with Cultivation to help customers and patients increase their medical health and treatments to improve their illnesses and Cancers. Press Release Contact: John Vivian CEO MEDcann Industries, Inc 813-699-4098 Safe Harbor Statement This press release contains statements, which may constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief, or current expectations of the Company, members of its management, and assumptions on which such statements are based. We caution prospective investors that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Contact Details MEDcann Industries, Inc John Vivian +1 813-699-4098

February 07, 2023 09:00 AM Eastern Standard Time

1 ... 162163164165166 ... 305